Astera Labs (NASDAQ:ALAB) Price Target Raised to $215.00

Astera Labs (NASDAQ:ALAB) had its price target hoisted by JPMorgan Chase & Co. from $180.00 to $215.00 in a research report released on Wednesday, MarketBeat Ratings reports. JPMorgan Chase & Co. currently has an overweight rating on the stock.

ALAB has been the topic of a number of other research reports. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Astera Labs from $160.00 to $200.00 and gave the stock a “buy” rating in a report on Tuesday, September 2nd. Jefferies Financial Group lifted their target price on Astera Labs from $95.00 to $130.00 and gave the stock a “buy” rating in a report on Tuesday, July 22nd. Zacks Research lowered Astera Labs from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 6th. CICC Research began coverage on Astera Labs in a research report on Friday, August 29th. They set an “outperform” rating and a $190.00 price objective for the company. Finally, Northland Securities lowered Astera Labs from an “outperform” rating to a “market perform” rating and set a $120.00 price objective on the stock. in a research note on Tuesday, July 22nd. Thirteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $181.59.

Astera Labs Stock Up 1.6%

Shares of ALAB opened at $165.49 on Wednesday. The stock has a market cap of $27.95 billion, a PE ratio of 149.09, a PEG ratio of 3.62 and a beta of 1.37. Astera Labs has a 12-month low of $47.13 and a 12-month high of $262.90. The business has a 50-day simple moving average of $195.98 and a two-hundred day simple moving average of $139.94.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Tuesday, November 4th. The company reported $0.49 earnings per share for the quarter, topping the consensus estimate of $0.39 by $0.10. The company had revenue of $230.58 million for the quarter, compared to analysts’ expectations of $206.42 million. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.The business’s quarterly revenue was up 103.9% compared to the same quarter last year. During the same period in the previous year, the business posted $0.23 earnings per share. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. On average, equities research analysts expect that Astera Labs will post 0.34 EPS for the current year.

Insider Activity at Astera Labs

In related news, CFO Michael Truett Tate sold 18,861 shares of the firm’s stock in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $183.51, for a total transaction of $3,461,182.11. Following the completion of the sale, the chief financial officer owned 259,512 shares of the company’s stock, valued at $47,623,047.12. This trade represents a 6.78% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, General Counsel Philip Mazzara sold 10,000 shares of Astera Labs stock in a transaction that occurred on Wednesday, October 1st. The stock was sold at an average price of $192.16, for a total value of $1,921,600.00. Following the completion of the sale, the general counsel owned 151,573 shares of the company’s stock, valued at approximately $29,126,267.68. The trade was a 6.19% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 534,480 shares of company stock worth $97,000,380 over the last quarter. 12.50% of the stock is owned by company insiders.

Institutional Investors Weigh In On Astera Labs

A number of large investors have recently bought and sold shares of ALAB. Assetmark Inc. raised its holdings in shares of Astera Labs by 374.1% during the third quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after purchasing an additional 101 shares during the period. Whittier Trust Co. bought a new stake in Astera Labs in the 3rd quarter valued at about $55,000. Atlantic Union Bankshares Corp raised its stake in Astera Labs by 1,338.1% during the 3rd quarter. Atlantic Union Bankshares Corp now owns 302 shares of the company’s stock worth $59,000 after buying an additional 281 shares during the period. Oliver Lagore Vanvalin Investment Group bought a new position in Astera Labs in the second quarter worth approximately $29,000. Finally, Grove Bank & Trust acquired a new stake in Astera Labs in the third quarter valued at approximately $68,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.